Compare BIO & CACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | CACC |
|---|---|---|
| Founded | 1952 | 1972 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance: Consumer Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 6.0B |
| IPO Year | N/A | 1996 |
| Metric | BIO | CACC |
|---|---|---|
| Price | $285.94 | $548.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $339.75 | ★ $505.00 |
| AVG Volume (30 Days) | ★ 431.5K | 137.1K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.00 |
| EPS | N/A | ★ 12.40 |
| Revenue | N/A | ★ $2,317,200,000.00 |
| Revenue This Year | $2.74 | $91.73 |
| Revenue Next Year | $3.20 | $3.58 |
| P/E Ratio | ★ $9.72 | $44.26 |
| Revenue Growth | N/A | ★ 7.16 |
| 52 Week Low | $222.80 | $401.90 |
| 52 Week High | $343.12 | $579.80 |
| Indicator | BIO | CACC |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 51.69 |
| Support Level | $256.85 | $533.11 |
| Resistance Level | $288.48 | $572.47 |
| Average True Range (ATR) | 9.54 | 19.25 |
| MACD | -2.00 | -2.59 |
| Stochastic Oscillator | 1.12 | 40.86 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.